featured
Efficacy and Safety of Cotadutide in Patients With Type 2 Diabetes and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of cotadutide, a dual GLP-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
Diabetes Obes Metab 2022 Apr 11;[EPub Ahead of Print], VER Parker, T Hoang, H Schlichthaar, FW Gibb, B Wenzel, MG Posch, L Rose, YT Chang, M Petrone, L Hansen, P Ambery, L Jermutus, HJL Heerspink, RJ McCrimmonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.